Korea Arlico Pharm Co Ltd banner

Intrinsic Value

Not Available for Korea Arlico Pharm Co Ltd

There is not enough data to reliably calculate the intrinsic value for Korea Arlico Pharm Co Ltd.

Do our valuations actually work? See backtest results .

Alternatives to Korea Arlico Pharm Co Ltd

Fundamental Analysis

What Korea Arlico Pharm Does

Pharmaceuticals Health Care

Korea Arlico Pharm Co., Ltd. engages in the provision of development and manufacture of pharmaceutical products. The company is headquartered in Seoul, Seoul and currently employs 228 full-time employees. The company went IPO on 2018-02-12. The firm manufactures and sells medicines such as hyperlipidemia, cerebrovascular disease, digestive medicine, allergies, respiratory medicine and others. In addition, the Company is also engaged in the manufacture of non-pharmaceutical products such as sun cream, hand cream and medical devices. The firm sells its products in domestic and overseas markets.

Headquarters
Korea KR
Employees
228
IPO date
Feb 12, 2018
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Korea Arlico Pharm Co Ltd

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape